Cancer Family

Lung Neoplasm

Non-malignant2,726 active trials51 approved drugs619 evidence items

NCIt: C3200
MeSH: D008175

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (483)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 76–100 of 483 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Reprogramming PD-L1 endosomal recycling and lysosomal degradation via engineered exosome-based nanocomposites overcomes immune resistance in lung cancer brain metastasis.
Xiujuan Hong, Xiaoqi Wang, Wankun Wang et al. · Mater Today Bio · Oct 1, 2026 · PMID 42729718 · candidate dictionary pubmed
Clinical utility of circulating tumor-derived endothelial cells in lung cancer detection and prognosis prediction.
Xiang Li, Jun Yang, Bin Chen et al. · Oncol Lett · Oct 1, 2026 · PMID 42729558 · candidate dictionary pubmed
GTV expert opinion: Optimizing photon radiation techniques and dosimetric constraints for locally advanced lung cancer with co-existing interstitial lung disease.
George J Li, Suresh Senan, Alexander V Louie · Radiother Oncol · Oct 1, 2026 · PMID 42785909 · candidate dictionary pubmed
GTV clinical scenario: protons vs photons in a patient with a second primary lung cancer and co-existing interstitial lung disease (ILD).
Sarah Bowen Jones, Aqeel Umar, Conal Hayton · Radiother Oncol · Oct 1, 2026 · PMID 42785907 · candidate dictionary pubmed
EVA1B promotes non-small cell lung cancer progression through an LRG1-associated mechanism.
Zhangzhou Huang, Haibo Wang, Kan Jiang et al. · 3 Biotech · Oct 1, 2026 · PMID 42781045 · candidate dictionary pubmed
Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer.
Lotte M G Hulskotte, G D Marijn Veerman, Daan A C Lanser et al. · EClinicalMedicine · Oct 1, 2026 · PMID 42775005 · candidate dictionary pubmed

Predictors of lung cancer patients' behavioral intention to use virtual reality for treatment preparedness and shared decision-making: a Unified Theory of Acceptance and Use of Technology-based perception study.

Safa Elkefi, Steven K Feiner, Alicia K Matthews et al. · JAMIA Open · Oct 1, 2026 · PMID 42798801 · candidate dictionary pubmed

Long-term exposure to wildfire-related PM2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study.

Min Zhang, Juan P Wisnivesky, Minghao Qiu et al. · Lancet Oncol · Oct 1, 2026 · PMID 42743939 · candidate dictionary pubmed

Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial.

Marloes J Hassing, Nicole E Billingy, Corina J G van den Hurk et al. · Lancet Oncol · Oct 1, 2026 · PMID 42727592 · candidate dictionary pubmed

From Real World Data to Real Impact: A Co-Medication Framework for Lung Cancer to Advance DDI Assessment and Patient-Centric Drug Development.

Mareena Biju, HeeJae Choi, Shilpa Madari et al. · Clin Transl Sci · Oct 1, 2026 · PMID 42813501 · candidate dictionary pubmed

Optimal, Interpretable, and Personalized Immune Checkpoint Inhibitor Duration in Non-Small Cell Lung Cancer: A Multicenter Real-World Study.

Siqi Wang, Jianhua Liu, Qiang Nie et al. · MedComm (2020) · Oct 1, 2026 · PMID 42812841 · candidate dictionary pubmed

Three Cases of Chylothorax After Lung Cancer Surgery: Possible Lymphatic Vessel Variation in the Upper Right Mediastinum.

Xiaoyun Li, Mei Xu, Mingyu Fan et al. · Clin Case Rep · Oct 1, 2026 · PMID 42812791 · candidate dictionary pubmed

Dynamic Predictions in Non-Small Cell Lung Cancer Using Joint Modeling of Longitudinal and Time-To-Event Outcomes Data.

Christopher R Pretz, Sara Wienke, Carin R Espenschied et al. · Cancer Med · Oct 1, 2026 · PMID 42802302 · candidate dictionary pubmed

Huangqi Guizhi Wuwu Decoction Ameliorates Cachexia in Lung Cancer Mice Through Regulating Amino Acid Metabolism: Insights From Transcriptomics, Metabolomics and Experimental Validation.

Yingjia Zhou, Shaoli Zhao, Hongmei Shen et al. · J Cell Mol Med · Oct 1, 2026 · PMID 42802147 · candidate dictionary pubmed

Pragmatic Screening for Sarcopenia in Non-Small Cell Lung Cancer: Development and Internal Validation of a Prospective Risk Model Integrating T12 CT Indices and Routine Clinical Variables.

Zhuorui You, Wei Dai, Hechen Shen et al. · Cancer Med · Oct 1, 2026 · PMID 42791661 · candidate dictionary pubmed

Mechanism of ORC1 Regulating Cancer Stemness and Cisplatin Resistance in Non-Small Cell Lung Cancer.

Jianhui Sheng, Yingjian Song · J Biochem Mol Toxicol · Oct 1, 2026 · PMID 42788364 · candidate dictionary pubmed

Atrial fibrillation and left bundle branch block followed by Brugada phenocopy induced by Entrectinib in a female Caucasian patient with metastatic non-small cell lung cancer: a case report.

Helen Triantafyllidi, Vasiliki Dragona, Charalambos Varlamos · Int Cancer Conf J · Oct 1, 2026 · PMID 42781027 · candidate dictionary pubmed

Intratumoral microbiota in the growth of CRC and lung cancer: Comprehensive insights from etiology to therapy.

Yicheng Wang, Jixiang Li, Xuxu Du et al. · iScience · Sep 18, 2026 · PMID 42668654 · candidate dictionary pubmed

EGFR T790M resistance mutation in non small-cell lung carcinoma.

· Clin Chim Acta · 2015 · PMID 25668228 · validated civic_curation pubmed

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

· N Engl J Med · 2010 · PMID 20979469 · validated civic_curation pubmed

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

· N Engl J Med · 2013 · PMID 23724913 · validated civic_curation pubmed

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

· N Engl J Med · 2014 · PMID 25470694 · validated civic_curation pubmed

Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.

· Lancet Oncol · 2016 · PMID 26708155 · validated civic_curation pubmed

Osimertinib: First Global Approval.

· Drugs · 2016 · PMID 26729184 · validated civic_curation pubmed

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

· N Engl J Med · 2017 · PMID 27959700 · validated civic_curation pubmed